| Product NDC: | 51672-1349 |
| Proprietary Name: | Risperidone |
| Non Proprietary Name: | Risperidone |
| Active Ingredient(s): | 1 mg/mL & nbsp; Risperidone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51672-1349 |
| Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090347 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110207 |
| Package NDC: | 51672-1349-3 |
| Package Description: | 1 BOTTLE in 1 CARTON (51672-1349-3) > 30 mL in 1 BOTTLE |
| NDC Code | 51672-1349-3 |
| Proprietary Name | Risperidone |
| Package Description | 1 BOTTLE in 1 CARTON (51672-1349-3) > 30 mL in 1 BOTTLE |
| Product NDC | 51672-1349 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Risperidone |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20110207 |
| Marketing Category Name | ANDA |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Substance Name | RISPERIDONE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |